These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17659211)

  • 1. Enterococci and streptococci.
    Amyes SG
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S43-52. PubMed ID: 17659211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.
    Brigante GR; Luzzaro FA; Pini B; Lombardi G; Sokeng G; Toniolo AQ
    BMC Microbiol; 2007 May; 7():46. PubMed ID: 17521437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
    Vachée A; Varon E; Jouy E; Meunier D;
    Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on the susceptibility of streptococci to antibiotics (enterococci and Streptococcus pneumoniae excluded)].
    Faibis F; Fiacre A; Demachy MC
    Ann Biol Clin (Paris); 2003; 61(1):49-59. PubMed ID: 12604386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characterization of Enterococcus spp. isolated from Brazilian foods.
    Gomes BC; Esteves CT; Palazzo IC; Darini AL; Felis GE; Sechi LA; Franco BD; De Martinis EC
    Food Microbiol; 2008 Aug; 25(5):668-75. PubMed ID: 18541165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms behind the development of antibiotic resistant bacteria].
    Gaustad P
    Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3090-4. PubMed ID: 11757446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci.
    Sadowy E
    Plasmid; 2018 Sep; 99():89-98. PubMed ID: 30253132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of antibiotic-resistant Gram-positive pathogens.
    Lode HM
    Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance genes in multidrug-resistant Enterococcus spp. and Streptococcus spp. recovered from the indoor air of a large-scale swine-feeding operation.
    Sapkota AR; Ojo KK; Roberts MC; Schwab KJ
    Lett Appl Microbiol; 2006 Nov; 43(5):534-40. PubMed ID: 17032228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Fritsche TR; Sader HS; Stillwell MG; Jones RN
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):440-6. PubMed ID: 19302928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular characterization of vancomycin-resistant enterococci isolates].
    Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals.
    Claesson C; Nilsson LE; Kronvall G; Walder M; Sörberg M
    Scand J Infect Dis; 2009; 41(3):171-81. PubMed ID: 19173129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
    Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
    Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.